These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 27528761)

  • 1. Regulation of the ALK1 ligands, BMP9 and BMP10.
    Li W; Salmon RM; Jiang H; Morrell NW
    Biochem Soc Trans; 2016 Aug; 44(4):1135-41. PubMed ID: 27528761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone morphogenetic protein 9 (BMP9) and BMP10 enhance tumor necrosis factor-α-induced monocyte recruitment to the vascular endothelium mainly via activin receptor-like kinase 2.
    Mitrofan CG; Appleby SL; Nash GB; Mallat Z; Chilvers ER; Upton PD; Morrell NW
    J Biol Chem; 2017 Aug; 292(33):13714-13726. PubMed ID: 28646109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A heterodimer formed by bone morphogenetic protein 9 (BMP9) and BMP10 provides most BMP biological activity in plasma.
    Tillet E; Ouarné M; Desroches-Castan A; Mallet C; Subileau M; Didier R; Lioutsko A; Belthier G; Feige JJ; Bailly S
    J Biol Chem; 2018 Jul; 293(28):10963-10974. PubMed ID: 29789425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells.
    Upton PD; Davies RJ; Trembath RC; Morrell NW
    J Biol Chem; 2009 Jun; 284(23):15794-804. PubMed ID: 19366699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of heterozygous ALK1 mutations on the transcriptomic response to BMP9 and BMP10 in endothelial cells from hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension donors.
    Al Tabosh T; Liu H; Koça D; Al Tarrass M; Tu L; Giraud S; Delagrange L; Beaudoin M; Rivière S; Grobost V; Rondeau-Lutz M; Dupuis O; Ricard N; Tillet E; Machillot P; Salomon A; Picart C; Battail C; Dupuis-Girod S; Guignabert C; Desroches-Castan A; Bailly S
    Angiogenesis; 2024 May; 27(2):211-227. PubMed ID: 38294582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of ALK1-mediated signalling by BMP9/BMP10 and their prodomain-bound forms.
    Salmon RM; Guo J; Wood JH; Tong Z; Beech JS; Lawera A; Yu M; Grainger DJ; Reckless J; Morrell NW; Li W
    Nat Commun; 2020 Apr; 11(1):1621. PubMed ID: 32238803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity and structure of a high affinity activin receptor-like kinase 1 (ALK1) signaling complex.
    Townson SA; Martinez-Hackert E; Greppi C; Lowden P; Sako D; Liu J; Ucran JA; Liharska K; Underwood KW; Seehra J; Kumar R; Grinberg AV
    J Biol Chem; 2012 Aug; 287(33):27313-25. PubMed ID: 22718755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells.
    David L; Mallet C; Mazerbourg S; Feige JJ; Bailly S
    Blood; 2007 Mar; 109(5):1953-61. PubMed ID: 17068149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMP10 functions independently from BMP9 for the development of a proper arteriovenous network.
    Choi H; Kim BG; Kim YH; Lee SJ; Lee YJ; Oh SP
    Angiogenesis; 2023 Feb; 26(1):167-186. PubMed ID: 36348215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMP9 and BMP10: Two close vascular quiescence partners that stand out.
    Desroches-Castan A; Tillet E; Bouvard C; Bailly S
    Dev Dyn; 2022 Jan; 251(1):178-197. PubMed ID: 34240497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMP9, but not BMP10, acts as a quiescence factor on tumor growth, vessel normalization and metastasis in a mouse model of breast cancer.
    Ouarné M; Bouvard C; Boneva G; Mallet C; Ribeiro J; Desroches-Castan A; Soleilhac E; Tillet E; Peyruchaud O; Bailly S
    J Exp Clin Cancer Res; 2018 Aug; 37(1):209. PubMed ID: 30165893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Context-dependent signaling defines roles of BMP9 and BMP10 in embryonic and postnatal development.
    Chen H; Brady Ridgway J; Sai T; Lai J; Warming S; Chen H; Roose-Girma M; Zhang G; Shou W; Yan M
    Proc Natl Acad Sci U S A; 2013 Jul; 110(29):11887-92. PubMed ID: 23812757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BMP9 and BMP10 are critical for postnatal retinal vascular remodeling.
    Ricard N; Ciais D; Levet S; Subileau M; Mallet C; Zimmers TA; Lee SJ; Bidart M; Feige JJ; Bailly S
    Blood; 2012 Jun; 119(25):6162-71. PubMed ID: 22566602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum/glucocorticoid-regulated kinase 1 as a novel transcriptional target of bone morphogenetic protein-ALK1 receptor signaling in vascular endothelial cells.
    Araki M; Hisamitsu T; Kinugasa-Katayama Y; Tanaka T; Harada Y; Nakao S; Hanada S; Ishii S; Fujita M; Kawamura T; Saito Y; Nishiyama K; Watanabe Y; Nakagawa O
    Angiogenesis; 2018 May; 21(2):415-423. PubMed ID: 29478089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALK1-Fc inhibits multiple mediators of angiogenesis and suppresses tumor growth.
    Mitchell D; Pobre EG; Mulivor AW; Grinberg AV; Castonguay R; Monnell TE; Solban N; Ucran JA; Pearsall RS; Underwood KW; Seehra J; Kumar R
    Mol Cancer Ther; 2010 Feb; 9(2):379-88. PubMed ID: 20124460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial protective factors BMP9 and BMP10 inhibit CCL2 release by human vascular endothelial cells.
    Upton PD; Park JES; De Souza PM; Davies RJ; Griffiths MJD; Wort SJ; Morrell NW
    J Cell Sci; 2020 Jul; 133(14):. PubMed ID: 32576665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging roles of BMP9 and BMP10 in hereditary hemorrhagic telangiectasia.
    Tillet E; Bailly S
    Front Genet; 2014; 5():456. PubMed ID: 25620979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMP9 and BMP10 Act Directly on Vascular Smooth Muscle Cells for Generation and Maintenance of the Contractile State.
    Wang L; Rice M; Swist S; Kubin T; Wu F; Wang S; Kraut S; Weissmann N; Böttger T; Wheeler M; Schneider A; Braun T
    Circulation; 2021 Apr; 143(14):1394-1410. PubMed ID: 33334130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-human activin receptor-like kinase 1 (ALK1) antibody attenuates bone morphogenetic protein 9 (BMP9)-induced ALK1 signaling and interferes with endothelial cell sprouting.
    van Meeteren LA; Thorikay M; Bergqvist S; Pardali E; Stampino CG; Hu-Lowe D; Goumans MJ; ten Dijke P
    J Biol Chem; 2012 May; 287(22):18551-61. PubMed ID: 22493445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BMP10-mediated ALK1 signaling is continuously required for vascular development and maintenance.
    Capasso TL; Li B; Volek HJ; Khalid W; Rochon ER; Anbalagan A; Herdman C; Yost HJ; Villanueva FS; Kim K; Roman BL
    Angiogenesis; 2020 May; 23(2):203-220. PubMed ID: 31828546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.